Loading
Latest filing published 06 Mar 2024 for Optomed Oyj, €114.
No signal scores available.
All filings by Juho-Pekka Himberg on record concern Optomed Oyj, in the capacity of chief executive. We count 2 filings; the first trade dates from 29 February 2024 and the latest from 5 March 2024.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
On 6 March 2024 came the latest disclosure, a transaction for €114 in Optomed Oyj. Source: insider filings from Nasdaq Helsinki. Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations